# FDA Inspection 1162418 - ReproTech, LTD. - February 14, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/reprotech-ltd/f8ed2887-0852-4a73-8f33-c50e92598bff/
Source feed: FDA_Inspections

> FDA Inspection 1162418 for ReproTech, LTD. on February 14, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1162418
- Company Name: ReproTech, LTD.
- Inspection Date: 2022-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1162418 - 2022-02-14](https://www.globalkeysolutions.net/api/records/fda_inspections/reprotech-ltd/5310f947-b32a-4309-8ab3-c5fe2ff10ab1/)
- [FDA Inspection 1007051 - 2017-03-07](https://www.globalkeysolutions.net/api/records/fda_inspections/reprotech-ltd/d0539a90-d554-4b15-aa87-2cc07fcec3da/)
- [FDA Inspection 853399 - 2013-10-30](https://www.globalkeysolutions.net/api/records/fda_inspections/reprotech-ltd/af9242c7-0001-4313-ab4d-7065265b5bc6/)

Company: https://www.globalkeysolutions.net/companies/reprotech-ltd/ef8d2532-54bc-4933-bf98-aca2869348ea

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d